CSTL - Castle Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CSTL is currently covered by 8 analysts with an average price target of $31.87. This is a potential upside of $14.85 (87.25%) from yesterday's end of day stock price of $17.02.

Castle Biosciences's activity chart (see below) currently has 86 price targets and 78 ratings on display. The stock rating distribution of CSTL is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 42.54% with an average time for these price targets to be met of 134.75 days.

Highest price target for CSTL is $41, Lowest price target is $36, average price target is $37.57.

Most recent stock forecast was given by SUNG JI NAM from SCOTIABANK on 21-May-2025. First documented stock forecast 19-Aug-2019.

Currently out of the existing stock ratings of CSTL, 27 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

$24.03 (150.47%)

$45

15 days ago
(21-May-2025)

4/13 (30.77%)

$23.98 (149.69%)

132

Buy

$37

$21.03 (131.68%)

$42

30 days ago
(06-May-2025)

1/7 (14.29%)

$20.38 (122.62%)

70

Buy

$41

$25.03 (156.73%)

$37

5 months 3 days ago
(02-Jan-2025)

0/5 (0%)

$12.96 (46.22%)

Buy

$39

$23.03 (144.21%)

$37

7 months ago
(05-Nov-2024)

4/14 (28.57%)

$7.85 (25.20%)

188

Buy

$36

$20.03 (125.42%)

$28

7 months ago
(05-Nov-2024)

4/7 (57.14%)

$4.85 (15.57%)

104

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CSTL (Castle Biosciences) average time for price targets to be met?

On average it took 134.75 days on average for the stock forecasts to be realized with a an average price target met ratio 42.54

Which analyst has the current highest performing score on CSTL (Castle Biosciences) with a proven track record?

THOMAS FLATEN

Which analyst has the current lower performing score on CSTL (Castle Biosciences) with a proven track record?

MASON CARRICO

Which analyst has the most public recommendations on CSTL (Castle Biosciences)?

Thomas Flaten works at LAKE STREET and has 5 price targets and 3 ratings on CSTL

Which analyst is the currently most bullish on CSTL (Castle Biosciences)?

Mason Carrico with highest potential upside - $25.03

Which analyst is the currently most reserved on CSTL (Castle Biosciences)?

Mark Massaro with lowest potential downside - $14.03

Castle Biosciences in the News

New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal Cancer

Additionally, an expert physician panel convened by EndoscopyNow will host a product theater on Sunday, May 4, at 2:45 p.m. Pacific Time, titled, “The Time is Now: A Clinical Practice Model to Help Prevent Progression from Barrett’s to EAC” FRIENDSWOOD, Texas, May 02, 2025 (GLOBE NEWSWIRE) — Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?